home / stock / pvct / pvct quote
Last: | $0.19305 |
---|---|
Change Percent: | -3.5% |
Open: | $0.198 |
Close: | $0.19305 |
High: | $0.198 |
Low: | $0.1901 |
Volume: | 128,865 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.19305 | $0.198 | $0.19305 | $0.198 | $0.1901 | 128,865 | 05-03-2024 |
$0.1913 | $0.195 | $0.1913 | $0.197965 | $0.1913 | 169,171 | 05-02-2024 |
$0.1949 | $0.198 | $0.1949 | $0.198 | $0.19 | 81,575 | 05-01-2024 |
$0.1979 | $0.199 | $0.1979 | $0.199 | $0.192 | 60,060 | 04-30-2024 |
$0.199 | $0.198917 | $0.199 | $0.199 | $0.1909 | 149,227 | 04-29-2024 |
$0.1985 | $0.1964 | $0.1985 | $0.1985 | $0.1901 | 39,686 | 04-26-2024 |
$0.1964 | $0.18792 | $0.1964 | $0.1964 | $0.1851 | 251,000 | 04-25-2024 |
$0.194 | $0.1948 | $0.194 | $0.1948 | $0.1809 | 67,734 | 04-24-2024 |
$0.1948 | $0.1948 | $0.1948 | $0.1948 | $0.19 | 138,051 | 04-23-2024 |
$0.1948 | $0.1948 | $0.1948 | $0.1948 | $0.19192 | 63,395 | 04-22-2024 |
$0.1948 | $0.1945 | $0.1948 | $0.1948 | $0.18 | 198,647 | 04-19-2024 |
$0.195 | $0.1968 | $0.195 | $0.1968 | $0.18756 | 56,479 | 04-18-2024 |
$0.19 | $0.17 | $0.19 | $0.19 | $0.1435 | 60,302 | 04-17-2024 |
$0.1799 | $0.1675 | $0.1799 | $0.1802 | $0.1585 | 676,310 | 04-16-2024 |
$0.1675 | $0.1601 | $0.1675 | $0.169 | $0.1601 | 52,451 | 04-15-2024 |
$0.1674 | $0.182 | $0.1674 | $0.182 | $0.165 | 25,580 | 04-12-2024 |
$0.1819 | $0.1697 | $0.1819 | $0.1989 | $0.1583 | 54,474 | 04-11-2024 |
$0.1697 | $0.1582 | $0.1697 | $0.17 | $0.1582 | 165,423 | 04-10-2024 |
$0.16 | $0.1487 | $0.16 | $0.164 | $0.137 | 84,423 | 04-09-2024 |
$0.14457 | $0.14 | $0.14457 | $0.1487 | $0.13724 | 420,940 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
Provectus Biopharmaceuticals Inc Company Name:
PVCT Stock Symbol:
OTCMKTS Market:
Provectus Biopharmaceuticals Inc Website:
KNOXVILLE, TN, May 02, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office has allowed patent application 17/232,393, titled “Halogenated Xant...
Research on breast, colorectal, head and neck, and testicular cancers Novel downregulation of WNK1 and Wnt signaling KNOXVILLE, TN, April 18, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announ...
Names Ed Pershing as Chief Executive Officer and Dominic Rodrigues as President KNOXVILLE, TN, April 16, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced additions to its executive leader...